IPO
DualityBio, Partner of BioNTech and BeiGene, Files for Hong Kong IPO, Highlighting Several Potential First-in-Class ADCs
2024-08-29
Global Pharmaceutical Investment in Asia: A Strategic Focus Amidst Evolving Market Dynamics
2024-03-12
Biotech and Pharma IPOs Surge with Innovative Therapies in the Beginning of 2024: From Kymera Therapeutics to Kyverna Therapeutics Lead the Way
2024-01-18
A Multi-Billion Budding Venture in Consumer Health, J&J’s Kenvue Aims to Raise $3.5 Billion in IPO
2023-04-27